» Articles » PMID: 35784198

The Diagnostic Value of the Thermostatic Amplification of Ribonucleic Acid in Bronchoalveolar Lavage Fluid in Smear-Negative Pulmonary Tuberculosis

Overview
Specialty Public Health
Date 2022 Jul 5
PMID 35784198
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to determine the value of the simultaneous amplification and testing for in bronchoalveolar lavage fluid (BALF) in the diagnosis of smear-negative pulmonary tuberculosis (PTB).

Methods: A total of 316 patients were selected, of which 197 had smear-negative PTB (observation group), and 119 did not have TB (control group). Bronchoscopy was performed in both groups, and BALF samples were collected for acid-fast bacilli smears, simultaneous amplification/testing for TB (SAT-TB), and BACTEC MGIT 960 cultures. The sensitivity, specificity, positive predictive, and negative predictive values of SAT-TB in BALF for the diagnosis of negative TB were calculated.

Results: The sensitivity of SAT-TB detection was 45.18%, which was significantly higher than smears and slightly lower than cultures. The specificity of SAT-TB was 99.16%, which differed slightly from the other two methods. The positive predictive value was 98.89%, which was not significantly different from the other two methods. The negative predictive value of SAT-TB was 58.91%, which was higher than smears and slightly lower than cultures.

Conclusion: The very high specificity and negative prediction of SAT-TB in BALF means that the method has great application value for the rapid diagnosis of smear-negative PTB.

Citing Articles

Diagnostic value of SAT-TB in smear-negative pulmonary tuberculosis: A diagnostic accuracy study.

Zhao X, Cui K, Bai L, Xu S, Liu W, Shang J Medicine (Baltimore). 2024; 103(50):e40907.

PMID: 39686443 PMC: 11651478. DOI: 10.1097/MD.0000000000040907.


Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis.

Li X, Zhao W, Han H, Yang Z, Bi F, He Y Saudi Med J. 2024; 45(7):658-666.

PMID: 38955446 PMC: 11237276. DOI: 10.15537/smj.2024.45.7.20240310.


Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens.

Yu G, Shen Y, Yao L, Xu X Infect Drug Resist. 2024; 17:673-682.

PMID: 38405053 PMC: 10887957. DOI: 10.2147/IDR.S442229.

References
1.
Brodie D, Schluger N . The diagnosis of tuberculosis. Clin Chest Med. 2005; 26(2):247-71, vi. DOI: 10.1016/j.ccm.2005.02.012. View

2.
Goessens W, de Man P, Koeleman J, Luijendijk A, Te Witt R, Endtz H . Comparison of the COBAS AMPLICOR MTB and BDProbeTec ET assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol. 2005; 43(6):2563-6. PMC: 1151882. DOI: 10.1128/JCM.43.6.2563-2566.2005. View

3.
Andersen A, Lillebaek T, Bang D, Prahl J . [Treatment and diagnostics of tuberculosis: moving slowly forward]. Ugeskr Laeger. 2011; 173(12):897-9. View

4.
Rasool G, Khan A, Mohy-Ud-Din R, Riaz M . Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert MTB/RIF assay. Int J Immunopathol Pharmacol. 2019; 33:2058738419827174. PMC: 6360468. DOI: 10.1177/2058738419827174. View

5.
Huang F, Dang L, Sun H, Yang H, Wu X . [A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2015; 38(9):680-5. View